Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.6258
+0.0169 (2.78%)
At close: Nov 26, 2025, 4:00 PM EST
0.6070
-0.0188 (-3.00%)
After-hours: Nov 26, 2025, 6:42 PM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $49.27 million as of November 26, 2025. Its market cap has decreased by -56.24% in one year.
Market Cap
49.27M
Enterprise Value
35.03M
1-Year Change
-56.24%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $226.28M to $49.27M, a decrease of -78.22%. That is a compound annual growth rate of -17.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 49.27M | -28.64% |
| Dec 31, 2024 | 69.05M | -42.03% |
| Dec 29, 2023 | 119.13M | -2.89% |
| Dec 30, 2022 | 122.67M | -65.85% |
| Dec 31, 2021 | 359.22M | -5.17% |
| Dec 31, 2020 | 378.78M | 3.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |